Skip to content

Fundus Findings and Thiol-Disulfide Homeostais

Fundus Findings and Thiol-Disulfide Homeostais in Gestational Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05958927
Enrollment
60
Registered
2023-07-25
Start date
2023-04-13
Completion date
2024-02-17
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases, Gestational Diabetes, Oxidative Stress, Retinal Disease

Brief summary

Gestational diabetes mellitus is associated with abnormal blood sugar levels throughout pregnancy in women without prior diabetes. Many studies have been conducted on the relationship between diabetes and oxidative stress. In this study, it was aimed to investigate the presence of fundus findings in patients with gestational diabetes and/or impaired blood sugar based on the results of previous studies and to simultaneously investigate the thiol-disulfide homeostasis in the tears of the patients.There was no previous study in the literature on thiol disulfide homeostasis in tears in gestational diabetic patients.

Detailed description

This is a prospective case-control study conducted in 26 pregnant patients diagnosed with gestational diabetes at 24-28 weeks of pregnancy and 34 healthy pregnant women without gestational diabetes in the Uşak Training and Research Hospital Gynecology and Ophthalmology clinic. Glucose tolerance test; If the plasma glucose was 140 mg/dl or higher in the 1st hour after an oral 50 g glucose load, 100 g glucose was added after 8 hours of fasting. The result of 100 gr OGTT was evaluated according to Carpenter and Coustan criteria. Gestational diabetes was diagnosed if two or more of the four glucose levels were abnormal according to the Carpenter and Coustan criteria. Gestational diabetes was diagnosed if the plasma glucose level was 200 mg and above in pregnant women who were loaded with 50 g glucose. A total of 60 pregnant women participated in the study. (26 gestational diabetes and 34 healthy pregnant women). Investigators excluded patients with type 1diabetes mellitus and type 2 diabetes mellitus, patient that history of ocular surface disease, topical/systemic medical therapy,with ocular inflamatuar disease such as üveitis. The patients who is healthy pregnant and gestasional diabetes mellitus pregnant were recruit to this study. Controls group included only healthy pregnant. Tears analysis is less invasive, safe and accaptable method for research All patients underwent a comprehensive ophthalmologic examination that included best-corrected visual acuity, slit-lamp examination, dilated fundus examination and applanation tonometry. Based on the International Clinical DR Disease Severity Scale (ICDRS). Tears analysis is less invasive, safe and accaptable method for research. Tear samples, Schirmer paper strips were placed in the lower conjunctival fornix of the right eye for a maximum of 5 minutes. Care was taken not to use tear stimulation, topical anesthetic or other eye drops. Attention was paid to factors such as lighting and room temperature. The ocular surface was not damaged. Tear samples were collected by a single individual (SD). A 15-20 mm test result was considered as enough for biochemical analysis. Schirmer strips were diluted with 500 μl previously cooled PBS (phosphate-buffered saline), and stored in Eppendorf tubes until analysis (-80 °C). At the end of the study, fundus findings and tear oxidative stress values of both groups will be compared.ELISA method will be used for determination of tear oxidative stress findings. The study followed the tenets of the declaration of Helsinki and was approved by the Uşak üniversitesi Ethics Committee (13.04.2023 / 93-93-04). Written and informed con-sent of participants was obtained for each patient prior to the study.

Interventions

OTHERtear test and eye measurement

tear test and eye measurement

Sponsors

Suzan Dogruya
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Example: Inclusion Criteria: * Healthy pregnant at 24-28 weeks of pregnancy * Pregnant patients diagnosed with gestational diabetes and/or impaired blood sugar at 24-28 weeks of pregnancy

Exclusion criteria

* Type 1diabetes mellitus, * Type 2 diabetes mellitus, * Patient that history of ocular surface disease, * Topical/systemic medical therapy with ocular inflamatuar disease such as üveitis.

Design outcomes

Primary

MeasureTime frameDescription
Glucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM26 weeks of pregnantAll patients underwent a 50-g GTT at any time of the day. Women with ≥ 140 mg/dL on the 50-g GTT in the first hour but with a normal 100-g oral GTT level were included in the hyperglycemia group. Women with a 50-g GTT level \< 140 mg/dL were categorized as normal and included in the control group

Secondary

MeasureTime frameDescription
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM26 weeks pregnant womenRetinal nerve fiber thickness and macular (µm) are measured by OCT in pregnant women with impaired blood sugar and/or gestational DM RNFL (mean, superior, inferior, nasal, temporal), mean central macular thickness, macula 3mm (mean, superior, inferior, nasal, temporal) and macula 6mm (mean, superior, inferior, nasal, temporal) were measured
Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM26 weeks of pregnantNative thiol values, total thiol and disulfide values in tears in the pregnant group with blood sugar disorders and/or gestational DM, and control group
Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM26 weeks of pregnantRetinal nerve fiber temporal quadrant thickness in the pregnant group with blood sugar disorders and/or gestational DM, and control group

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

medical clinic

Pre-assignment details

women with impaired glucose status and normal glucose status

Participants by arm

ArmCount
Control Group
Non diabetic women tear test and eye measurement: tear test and eye measurement
34
Case Group
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
26
Total60

Baseline characteristics

CharacteristicCase GroupTotalControl Group
Age, Continuous28.30 years
STANDARD_DEVIATION 4.81
27.05 years
STANDARD_DEVIATION 4.86
25.94 years
STANDARD_DEVIATION 4.5
BMI27.76 kg/m²
STANDARD_DEVIATION 5.93
27.85 kg/m²
STANDARD_DEVIATION 5.605
27.94 kg/m²
STANDARD_DEVIATION 5.28
Mean RNFL, Temporal RNFL, CMT
CMT Mean (standard Deviation) Unit of measure:µm
252.08 µm
STANDARD_DEVIATION 18.36
249.33 µm
STANDARD_DEVIATION 18.85
246.59 µm
STANDARD_DEVIATION 19.35
Mean RNFL, Temporal RNFL, CMT
Mean RNFL Mean (standard Deviation) Unit of measure:µm
100.23 µm
STANDARD_DEVIATION 10.87
101.07 µm
STANDARD_DEVIATION 10.6
101.91 µm
STANDARD_DEVIATION 10.34
Mean RNFL, Temporal RNFL, CMT
RNFL Temporal Mean (standard Deviation) Unit of measure:µm
70.81 µm
STANDARD_DEVIATION 16.43
75.67 µm
STANDARD_DEVIATION 15.75
80.53 µm
STANDARD_DEVIATION 15.08
oxidative stress markers
Disülfide Mean(Standart Deviation) Unit of measure: mmol/L
8.75 mmol/L
STANDARD_DEVIATION 1.84
9.75 mmol/L
STANDARD_DEVIATION 4.17
10.76 mmol/L
STANDARD_DEVIATION 6.5
oxidative stress markers
Native Thiol Mean(Standart Deviation) Unit of measure: mmol/L
2.31 mmol/L
STANDARD_DEVIATION 2.48
8.13 mmol/L
STANDARD_DEVIATION 20.7
13.96 mmol/L
STANDARD_DEVIATION 38.93
oxidative stress markers
Total Thiol Mean(Standart Deviation) Unit of measure: mmol/L
19.76 mmol/L
STANDARD_DEVIATION 2.93
27.25 mmol/L
STANDARD_DEVIATION 25.68
34.75 mmol/L
STANDARD_DEVIATION 48.44
Race/Ethnicity, Customized26 Participants60 Participants34 Participants
Region of Enrollment
Turkey
26 Participants60 Participants34 Participants
Sex: Female, Male
Female
26 Participants60 Participants34 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 26
other
Total, other adverse events
0 / 340 / 26
serious
Total, serious adverse events
0 / 340 / 26

Outcome results

Primary

Glucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

All patients underwent a 50-g GTT at any time of the day. Women with ≥ 140 mg/dL on the 50-g GTT in the first hour but with a normal 100-g oral GTT level were included in the hyperglycemia group. Women with a 50-g GTT level \< 140 mg/dL were categorized as normal and included in the control group

Time frame: 26 weeks of pregnant

Population: 34 control pregnant women and 26 pregnant women with impaired glucose tolerance were compared with fasting blood glucose and blood glucose at the 1st hour after 50 g sugar loading.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupGlucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM50 gr (1hour) Mean(Standart Deviation) Unit of measure: mg/dl111.67 mg/dlStandard Error 25.54
Control GroupGlucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DMFasting food sugar Mean(Standart Deviation) Unit of measure: mg/dl83.06 mg/dlStandard Error 11.33
Case GroupGlucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM50 gr (1hour) Mean(Standart Deviation) Unit of measure: mg/dl154 mg/dlStandard Error 24.29
Case GroupGlucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DMFasting food sugar Mean(Standart Deviation) Unit of measure: mg/dl88.15 mg/dlStandard Error 14.33
Secondary

Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

Native thiol values, total thiol and disulfide values in tears in the pregnant group with blood sugar disorders and/or gestational DM, and control group

Time frame: 26 weeks of pregnant

Population: Natural thiol values, total thiol and disulphide values in tears of 26 pregnant women with blood glucose disorders and/or gestational DM and 34 control subjects

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNative Thiol Mean(Standart Deviation) Unit of measure: mmol/L13.96 mmol/LStandard Deviation 38.93
Control GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTotal Thiol Mean(Standart Deviation) Unit of measure: mmol/L34.75 mmol/LStandard Deviation 48.44
Control GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMDisülfide Mean(Standart Deviation) Unit of measure: mmol/L10.76 mmol/LStandard Deviation 6.5
Case GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMDisülfide Mean(Standart Deviation) Unit of measure: mmol/L8.75 mmol/LStandard Deviation 1.84
Case GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNative Thiol Mean(Standart Deviation) Unit of measure: mmol/L2.31 mmol/LStandard Deviation 2.48
Case GroupOxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTotal Thiol Mean(Standart Deviation) Unit of measure: mmol/L19.76 mmol/LStandard Deviation 2.93
Secondary

Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

Retinal nerve fiber temporal quadrant thickness in the pregnant group with blood sugar disorders and/or gestational DM, and control group

Time frame: 26 weeks of pregnant

Population: Retinal nerve fibre temporal quadrant thicknesses were measured in tears of 26 pregnant women with blood glucose disorders and/or gestational DM and 34 control subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTemporal RNFL Mean(Standart Deviation) Unit of measure:µm80.53 µmStandard Deviation 15.08
Control GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNasal RNFL Mean(Standart Deviation) Unit of measure:µm72.12 µmStandard Deviation 10.65
Control GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMSuperior RNFL Mean(Standart Deviation) Unit of measure:µm123.82 µmStandard Deviation 16.05
Control GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMInferior RNFL Mean(Standart Deviation) Unit of measure:µm132.59 µmStandard Deviation 15.92
Case GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMInferior RNFL Mean(Standart Deviation) Unit of measure:µm128.23 µmStandard Deviation 20.6
Case GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTemporal RNFL Mean(Standart Deviation) Unit of measure:µm70.81 µmStandard Deviation 16.43
Case GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMSuperior RNFL Mean(Standart Deviation) Unit of measure:µm124.85 µmStandard Deviation 15.78
Case GroupRetinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNasal RNFL Mean(Standart Deviation) Unit of measure:µm72.27 µmStandard Deviation 11.81
Secondary

Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM

Retinal nerve fiber thickness and macular (µm) are measured by OCT in pregnant women with impaired blood sugar and/or gestational DM RNFL (mean, superior, inferior, nasal, temporal), mean central macular thickness, macula 3mm (mean, superior, inferior, nasal, temporal) and macula 6mm (mean, superior, inferior, nasal, temporal) were measured

Time frame: 26 weeks pregnant women

Population: Retinal nerve fibre thickness and macular thickness were measured in 26 pregnant women with blood glucose disorders and/or gestational DM and 24 pregnant women in the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMean RNFL Mean(Standart Deviation) Unit of measure:µm101.91 µmStandard Error 10.34
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMSuperior RNFL Mean(Standart Deviation) Unit of measure:µm123.82 µmStandard Error 16.05
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMInferior RNFL Mean(Standart Deviation) Unit of measure:µm132.59 µmStandard Error 15.92
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNasal RNFL Mean(Standart Deviation) Unit of measure:µm72.12 µmStandard Error 10.65
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTemporal RNFL Mean(Standart Deviation) Unit of measure:µm80.53 µmStandard Error 15.08
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula CMT Mean(Standart Deviation) Unit of measure:µm246.59 µmStandard Error 19.35
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Superior Mean(Standart Deviation) Unit of measure:µm330.5 µmStandard Error 14.79
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Inferior Mean(Standart Deviation) Unit of measure:µm326.91 µmStandard Error 15.33
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Nasal Mean(Standart Deviation) Unit of measure:µm313.97 µmStandard Error 11.98
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Temporal Mean(Standart Deviation) Unit of measure:µm330.88 µmStandard Error 13.51
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Superior Mean(Standart Deviation) Unit of measure:µm299.21 µmStandard Error 12.36
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Inferior Mean(Standart Deviation) Unit of measure:µm292.32 µmStandard Error 22.82
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Nasal Mean(Standart Deviation) Unit of measure:µm280.44 µmStandard Error 11.52
Control GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Temporal Mean(Standart Deviation) Unit of measure:µm311.00 µmStandard Error 10.88
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Superior Mean(Standart Deviation) Unit of measure:µm298.19 µmStandard Error 12.72
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMean RNFL Mean(Standart Deviation) Unit of measure:µm100.23 µmStandard Error 10.87
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Inferior Mean(Standart Deviation) Unit of measure:µm330.92 µmStandard Error 15.33
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMSuperior RNFL Mean(Standart Deviation) Unit of measure:µm124.85 µmStandard Error 15.78
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Nasal Mean(Standart Deviation) Unit of measure:µm283.81 µmStandard Error 10.26
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMInferior RNFL Mean(Standart Deviation) Unit of measure:µm128.23 µmStandard Error 20.6
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Nasal Mean(Standart Deviation) Unit of measure:µm316.88 µmStandard Error 17.15
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMNasal RNFL Mean(Standart Deviation) Unit of measure:µm72.27 µmStandard Error 11.81
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Inferior Mean(Standart Deviation) Unit of measure:µm285.00 µmStandard Error 10.1
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMTemporal RNFL Mean(Standart Deviation) Unit of measure:µm70.81 µmStandard Error 16.43
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Temporal Mean(Standart Deviation) Unit of measure:µm330.65 µmStandard Error 12.48
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula CMT Mean(Standart Deviation) Unit of measure:µm252.08 µmStandard Error 18.36
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 6mm Temporal Mean(Standart Deviation) Unit of measure:µm307.92 µmStandard Error 12.84
Case GroupRetinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DMMacula 3mm Superior Mean(Standart Deviation) Unit of measure:µm333.5 µmStandard Error 14.94

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026